These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease. Mouradian MM; Heuser IJ; Baronti F; Chase TN Ann Neurol; 1990 Jan; 27(1):18-23. PubMed ID: 2301923 [TBL] [Abstract][Full Text] [Related]
6. Dopamine and memory function in Parkinson's disease. Mohr E; Fabbrini G; Williams J; Schlegel J; Cox C; Fedio P; Chase TN Mov Disord; 1989; 4(2):113-20. PubMed ID: 2543918 [TBL] [Abstract][Full Text] [Related]
7. [Changes in the nigrostriatal dopamine receptor compartment after continuous dopaminergic infusions in Parkinson disease]. Baronti F; Ruggieri S; Mouradian MM; Bonamartini A; Bocciarelli P; De Pandis MF; Chase TN; Agnoli A Riv Neurol; 1991; 61(6):210-4. PubMed ID: 1813972 [TBL] [Abstract][Full Text] [Related]
8. Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease. Nyholm D Expert Rev Neurother; 2006 Oct; 6(10):1403-11. PubMed ID: 17078781 [TBL] [Abstract][Full Text] [Related]
9. Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease. Antonini A; Mancini F; Canesi M; Zangaglia R; Isaias IU; Manfredi L; Pacchetti C; Zibetti M; Natuzzi F; Lopiano L; Nappi G; Pezzoli G Neurodegener Dis; 2008; 5(3-4):244-6. PubMed ID: 18322402 [TBL] [Abstract][Full Text] [Related]